 | • レポートコード：QFJ1-5622 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ビオチニダーゼ欠損症の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（重度ビオチニダーゼ欠損症、部分的ビオチニダーゼ欠損症）、用途別市場規模（病院、専門クリニック、ドラッグストア、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ビオチニダーゼ欠損症の市場動向 ・企業の競争状況、市場シェア ・ビオチニダーゼ欠損症の種類別市場規模と予測2016-2027（重度ビオチニダーゼ欠損症、部分的ビオチニダーゼ欠損症） ・ビオチニダーゼ欠損症の用途別市場規模と予測2016-2027（病院、専門クリニック、ドラッグストア、小売薬局、オンライン薬局） ・ビオチニダーゼ欠損症の北米市場規模2016-2027（アメリカ、カナダ） ・ビオチニダーゼ欠損症の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ビオチニダーゼ欠損症のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ビオチニダーゼ欠損症の中南米市場規模2016-2027（メキシコ、ブラジル） ・ビオチニダーゼ欠損症の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Life Garden Naturals、Zhou Nutrition LLC (Nutraceutical International Corporation)、Pure Research Products LLC、SBR Nutrition、Natrol LLC、Church & Dwight Co. Inc.、Zenwise Health LLC） ・結論 |
Biotinidase deficiency (vitamin H or vitamin B7) is a genetic disorder in which biotin and vitamin are not recycled in the body and caused by mutation in BTD gene. But in humans, biotinidase deficiency is a rare disorder. Also, biotinidase deficiency can occur when an individual comprises rare inborn metabolism errors of holocarboxylase synthetase. Biotinidase deficiency is an autosomal recessive disorder. While it may convert into severe biotinidase deficiency with the dermatological and neurological presentation. Across the world, biotinidase deficiency is very common in pregnancy.
Market Analysis and Insights: Global Biotinidase Deficiency Market
The global Biotinidase Deficiency market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biotinidase Deficiency market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biotinidase Deficiency market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biotinidase Deficiency market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biotinidase Deficiency market.
Global Biotinidase Deficiency Scope and Market Size
Biotinidase Deficiency market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biotinidase Deficiency market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Profound Biotinidase Deficiency
Partial Biotinidase Deficiency
Segment by Application
Hospitals
Speciality Clinics
Drug Stores
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Life Garden Naturals
Zhou Nutrition LLC (Nutraceutical International Corporation)
Pure Research Products LLC
SBR Nutrition
Natrol LLC
Church & Dwight Co. Inc.
Zenwise Health LLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotinidase Deficiency Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Profound Biotinidase Deficiency
1.2.3 Partial Biotinidase Deficiency
1.3 Market by Application
1.3.1 Global Biotinidase Deficiency Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Speciality Clinics
1.3.4 Drug Stores
1.3.5 Retail Pharmacy
1.3.6 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biotinidase Deficiency Market Perspective (2016-2027)
2.2 Biotinidase Deficiency Growth Trends by Regions
2.2.1 Biotinidase Deficiency Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biotinidase Deficiency Historic Market Share by Regions (2016-2021)
2.2.3 Biotinidase Deficiency Forecasted Market Size by Regions (2022-2027)
2.3 Biotinidase Deficiency Industry Dynamic
2.3.1 Biotinidase Deficiency Market Trends
2.3.2 Biotinidase Deficiency Market Drivers
2.3.3 Biotinidase Deficiency Market Challenges
2.3.4 Biotinidase Deficiency Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotinidase Deficiency Players by Revenue
3.1.1 Global Top Biotinidase Deficiency Players by Revenue (2016-2021)
3.1.2 Global Biotinidase Deficiency Revenue Market Share by Players (2016-2021)
3.2 Global Biotinidase Deficiency Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biotinidase Deficiency Revenue
3.4 Global Biotinidase Deficiency Market Concentration Ratio
3.4.1 Global Biotinidase Deficiency Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotinidase Deficiency Revenue in 2020
3.5 Biotinidase Deficiency Key Players Head office and Area Served
3.6 Key Players Biotinidase Deficiency Product Solution and Service
3.7 Date of Enter into Biotinidase Deficiency Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotinidase Deficiency Breakdown Data by Type
4.1 Global Biotinidase Deficiency Historic Market Size by Type (2016-2021)
4.2 Global Biotinidase Deficiency Forecasted Market Size by Type (2022-2027)
5 Biotinidase Deficiency Breakdown Data by Application
5.1 Global Biotinidase Deficiency Historic Market Size by Application (2016-2021)
5.2 Global Biotinidase Deficiency Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biotinidase Deficiency Market Size (2016-2027)
6.2 North America Biotinidase Deficiency Market Size by Type
6.2.1 North America Biotinidase Deficiency Market Size by Type (2016-2021)
6.2.2 North America Biotinidase Deficiency Market Size by Type (2022-2027)
6.2.3 North America Biotinidase Deficiency Market Size by Type (2016-2027)
6.3 North America Biotinidase Deficiency Market Size by Application
6.3.1 North America Biotinidase Deficiency Market Size by Application (2016-2021)
6.3.2 North America Biotinidase Deficiency Market Size by Application (2022-2027)
6.3.3 North America Biotinidase Deficiency Market Size by Application (2016-2027)
6.4 North America Biotinidase Deficiency Market Size by Country
6.4.1 North America Biotinidase Deficiency Market Size by Country (2016-2021)
6.4.2 North America Biotinidase Deficiency Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biotinidase Deficiency Market Size (2016-2027)
7.2 Europe Biotinidase Deficiency Market Size by Type
7.2.1 Europe Biotinidase Deficiency Market Size by Type (2016-2021)
7.2.2 Europe Biotinidase Deficiency Market Size by Type (2022-2027)
7.2.3 Europe Biotinidase Deficiency Market Size by Type (2016-2027)
7.3 Europe Biotinidase Deficiency Market Size by Application
7.3.1 Europe Biotinidase Deficiency Market Size by Application (2016-2021)
7.3.2 Europe Biotinidase Deficiency Market Size by Application (2022-2027)
7.3.3 Europe Biotinidase Deficiency Market Size by Application (2016-2027)
7.4 Europe Biotinidase Deficiency Market Size by Country
7.4.1 Europe Biotinidase Deficiency Market Size by Country (2016-2021)
7.4.2 Europe Biotinidase Deficiency Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biotinidase Deficiency Market Size (2016-2027)
8.2 Asia-Pacific Biotinidase Deficiency Market Size by Type
8.2.1 Asia-Pacific Biotinidase Deficiency Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biotinidase Deficiency Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biotinidase Deficiency Market Size by Type (2016-2027)
8.3 Asia-Pacific Biotinidase Deficiency Market Size by Application
8.3.1 Asia-Pacific Biotinidase Deficiency Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biotinidase Deficiency Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biotinidase Deficiency Market Size by Application (2016-2027)
8.4 Asia-Pacific Biotinidase Deficiency Market Size by Region
8.4.1 Asia-Pacific Biotinidase Deficiency Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biotinidase Deficiency Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biotinidase Deficiency Market Size (2016-2027)
9.2 Latin America Biotinidase Deficiency Market Size by Type
9.2.1 Latin America Biotinidase Deficiency Market Size by Type (2016-2021)
9.2.2 Latin America Biotinidase Deficiency Market Size by Type (2022-2027)
9.2.3 Latin America Biotinidase Deficiency Market Size by Type (2016-2027)
9.3 Latin America Biotinidase Deficiency Market Size by Application
9.3.1 Latin America Biotinidase Deficiency Market Size by Application (2016-2021)
9.3.2 Latin America Biotinidase Deficiency Market Size by Application (2022-2027)
9.3.3 Latin America Biotinidase Deficiency Market Size by Application (2016-2027)
9.4 Latin America Biotinidase Deficiency Market Size by Country
9.4.1 Latin America Biotinidase Deficiency Market Size by Country (2016-2021)
9.4.2 Latin America Biotinidase Deficiency Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotinidase Deficiency Market Size (2016-2027)
10.2 Middle East & Africa Biotinidase Deficiency Market Size by Type
10.2.1 Middle East & Africa Biotinidase Deficiency Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biotinidase Deficiency Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biotinidase Deficiency Market Size by Type (2016-2027)
10.3 Middle East & Africa Biotinidase Deficiency Market Size by Application
10.3.1 Middle East & Africa Biotinidase Deficiency Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biotinidase Deficiency Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biotinidase Deficiency Market Size by Application (2016-2027)
10.4 Middle East & Africa Biotinidase Deficiency Market Size by Country
10.4.1 Middle East & Africa Biotinidase Deficiency Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biotinidase Deficiency Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Life Garden Naturals
11.1.1 Life Garden Naturals Company Details
11.1.2 Life Garden Naturals Business Overview
11.1.3 Life Garden Naturals Biotinidase Deficiency Introduction
11.1.4 Life Garden Naturals Revenue in Biotinidase Deficiency Business (2016-2021)
11.1.5 Life Garden Naturals Recent Development
11.2 Zhou Nutrition LLC (Nutraceutical International Corporation)
11.2.1 Zhou Nutrition LLC (Nutraceutical International Corporation) Company Details
11.2.2 Zhou Nutrition LLC (Nutraceutical International Corporation) Business Overview
11.2.3 Zhou Nutrition LLC (Nutraceutical International Corporation) Biotinidase Deficiency Introduction
11.2.4 Zhou Nutrition LLC (Nutraceutical International Corporation) Revenue in Biotinidase Deficiency Business (2016-2021)
11.2.5 Zhou Nutrition LLC (Nutraceutical International Corporation) Recent Development
11.3 Pure Research Products LLC
11.3.1 Pure Research Products LLC Company Details
11.3.2 Pure Research Products LLC Business Overview
11.3.3 Pure Research Products LLC Biotinidase Deficiency Introduction
11.3.4 Pure Research Products LLC Revenue in Biotinidase Deficiency Business (2016-2021)
11.3.5 Pure Research Products LLC Recent Development
11.4 SBR Nutrition
11.4.1 SBR Nutrition Company Details
11.4.2 SBR Nutrition Business Overview
11.4.3 SBR Nutrition Biotinidase Deficiency Introduction
11.4.4 SBR Nutrition Revenue in Biotinidase Deficiency Business (2016-2021)
11.4.5 SBR Nutrition Recent Development
11.5 Natrol LLC
11.5.1 Natrol LLC Company Details
11.5.2 Natrol LLC Business Overview
11.5.3 Natrol LLC Biotinidase Deficiency Introduction
11.5.4 Natrol LLC Revenue in Biotinidase Deficiency Business (2016-2021)
11.5.5 Natrol LLC Recent Development
11.6 Church & Dwight Co. Inc.
11.6.1 Church & Dwight Co. Inc. Company Details
11.6.2 Church & Dwight Co. Inc. Business Overview
11.6.3 Church & Dwight Co. Inc. Biotinidase Deficiency Introduction
11.6.4 Church & Dwight Co. Inc. Revenue in Biotinidase Deficiency Business (2016-2021)
11.6.5 Church & Dwight Co. Inc. Recent Development
11.7 Zenwise Health LLC
11.7.1 Zenwise Health LLC Company Details
11.7.2 Zenwise Health LLC Business Overview
11.7.3 Zenwise Health LLC Biotinidase Deficiency Introduction
11.7.4 Zenwise Health LLC Revenue in Biotinidase Deficiency Business (2016-2021)
11.7.5 Zenwise Health LLC Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biotinidase Deficiency Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Profound Biotinidase Deficiency
Table 3. Key Players of Partial Biotinidase Deficiency
Table 4. Global Biotinidase Deficiency Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biotinidase Deficiency Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biotinidase Deficiency Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biotinidase Deficiency Market Share by Regions (2016-2021)
Table 8. Global Biotinidase Deficiency Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biotinidase Deficiency Market Share by Regions (2022-2027)
Table 10. Biotinidase Deficiency Market Trends
Table 11. Biotinidase Deficiency Market Drivers
Table 12. Biotinidase Deficiency Market Challenges
Table 13. Biotinidase Deficiency Market Restraints
Table 14. Global Biotinidase Deficiency Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biotinidase Deficiency Market Share by Players (2016-2021)
Table 16. Global Top Biotinidase Deficiency Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biotinidase Deficiency as of 2020)
Table 17. Ranking of Global Top Biotinidase Deficiency Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biotinidase Deficiency Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biotinidase Deficiency Product Solution and Service
Table 21. Date of Enter into Biotinidase Deficiency Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biotinidase Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biotinidase Deficiency Revenue Market Share by Type (2016-2021)
Table 25. Global Biotinidase Deficiency Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biotinidase Deficiency Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biotinidase Deficiency Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biotinidase Deficiency Revenue Market Share by Application (2016-2021)
Table 29. Global Biotinidase Deficiency Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biotinidase Deficiency Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biotinidase Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biotinidase Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biotinidase Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biotinidase Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biotinidase Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biotinidase Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biotinidase Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biotinidase Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biotinidase Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biotinidase Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biotinidase Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biotinidase Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biotinidase Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biotinidase Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biotinidase Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biotinidase Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biotinidase Deficiency Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biotinidase Deficiency Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biotinidase Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biotinidase Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biotinidase Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biotinidase Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biotinidase Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biotinidase Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biotinidase Deficiency Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biotinidase Deficiency Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biotinidase Deficiency Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biotinidase Deficiency Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biotinidase Deficiency Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biotinidase Deficiency Market Size by Country (2022-2027) & (US$ Million)
Table 61. Life Garden Naturals Company Details
Table 62. Life Garden Naturals Business Overview
Table 63. Life Garden Naturals Biotinidase Deficiency Product
Table 64. Life Garden Naturals Revenue in Biotinidase Deficiency Business (2016-2021) & (US$ Million)
Table 65. Life Garden Naturals Recent Development
Table 66. Zhou Nutrition LLC (Nutraceutical International Corporation) Company Details
Table 67. Zhou Nutrition LLC (Nutraceutical International Corporation) Business Overview
Table 68. Zhou Nutrition LLC (Nutraceutical International Corporation) Biotinidase Deficiency Product
Table 69. Zhou Nutrition LLC (Nutraceutical International Corporation) Revenue in Biotinidase Deficiency Business (2016-2021) & (US$ Million)
Table 70. Zhou Nutrition LLC (Nutraceutical International Corporation) Recent Development
Table 71. Pure Research Products LLC Company Details
Table 72. Pure Research Products LLC Business Overview
Table 73. Pure Research Products LLC Biotinidase Deficiency Product
Table 74. Pure Research Products LLC Revenue in Biotinidase Deficiency Business (2016-2021) & (US$ Million)
Table 75. Pure Research Products LLC Recent Development
Table 76. SBR Nutrition Company Details
Table 77. SBR Nutrition Business Overview
Table 78. SBR Nutrition Biotinidase Deficiency Product
Table 79. SBR Nutrition Revenue in Biotinidase Deficiency Business (2016-2021) & (US$ Million)
Table 80. SBR Nutrition Recent Development
Table 81. Natrol LLC Company Details
Table 82. Natrol LLC Business Overview
Table 83. Natrol LLC Biotinidase Deficiency Product
Table 84. Natrol LLC Revenue in Biotinidase Deficiency Business (2016-2021) & (US$ Million)
Table 85. Natrol LLC Recent Development
Table 86. Church & Dwight Co. Inc. Company Details
Table 87. Church & Dwight Co. Inc. Business Overview
Table 88. Church & Dwight Co. Inc. Biotinidase Deficiency Product
Table 89. Church & Dwight Co. Inc. Revenue in Biotinidase Deficiency Business (2016-2021) & (US$ Million)
Table 90. Church & Dwight Co. Inc. Recent Development
Table 91. Zenwise Health LLC Company Details
Table 92. Zenwise Health LLC Business Overview
Table 93. Zenwise Health LLC Biotinidase Deficiency Product
Table 94. Zenwise Health LLC Revenue in Biotinidase Deficiency Business (2016-2021) & (US$ Million)
Table 95. Zenwise Health LLC Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotinidase Deficiency Market Share by Type: 2020 VS 2027
Figure 2. Profound Biotinidase Deficiency Features
Figure 3. Partial Biotinidase Deficiency Features
Figure 4. Global Biotinidase Deficiency Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Speciality Clinics Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Biotinidase Deficiency Report Years Considered
Figure 11. Global Biotinidase Deficiency Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Biotinidase Deficiency Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Biotinidase Deficiency Market Share by Regions: 2020 VS 2027
Figure 14. Global Biotinidase Deficiency Market Share by Regions (2022-2027)
Figure 15. Global Biotinidase Deficiency Market Share by Players in 2020
Figure 16. Global Top Biotinidase Deficiency Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biotinidase Deficiency as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Biotinidase Deficiency Revenue in 2020
Figure 18. Global Biotinidase Deficiency Revenue Market Share by Type (2016-2021)
Figure 19. Global Biotinidase Deficiency Revenue Market Share by Type (2022-2027)
Figure 20. North America Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Biotinidase Deficiency Market Share by Type (2016-2027)
Figure 22. North America Biotinidase Deficiency Market Share by Application (2016-2027)
Figure 23. North America Biotinidase Deficiency Market Share by Country (2016-2027)
Figure 24. United States Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Biotinidase Deficiency Market Share by Type (2016-2027)
Figure 28. Europe Biotinidase Deficiency Market Share by Application (2016-2027)
Figure 29. Europe Biotinidase Deficiency Market Share by Country (2016-2027)
Figure 30. Germany Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Biotinidase Deficiency Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Biotinidase Deficiency Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Biotinidase Deficiency Market Share by Region (2016-2027)
Figure 40. China Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Biotinidase Deficiency Market Share by Type (2016-2027)
Figure 48. Latin America Biotinidase Deficiency Market Share by Application (2016-2027)
Figure 49. Latin America Biotinidase Deficiency Market Share by Country (2016-2027)
Figure 50. Mexico Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Biotinidase Deficiency Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Biotinidase Deficiency Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Biotinidase Deficiency Market Share by Country (2016-2027)
Figure 56. Turkey Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Biotinidase Deficiency Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Life Garden Naturals Revenue Growth Rate in Biotinidase Deficiency Business (2016-2021)
Figure 60. Zhou Nutrition LLC (Nutraceutical International Corporation) Revenue Growth Rate in Biotinidase Deficiency Business (2016-2021)
Figure 61. Pure Research Products LLC Revenue Growth Rate in Biotinidase Deficiency Business (2016-2021)
Figure 62. SBR Nutrition Revenue Growth Rate in Biotinidase Deficiency Business (2016-2021)
Figure 63. Natrol LLC Revenue Growth Rate in Biotinidase Deficiency Business (2016-2021)
Figure 64. Church & Dwight Co. Inc. Revenue Growth Rate in Biotinidase Deficiency Business (2016-2021)
Figure 65. Zenwise Health LLC Revenue Growth Rate in Biotinidase Deficiency Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のACTH欠乏症治療市場規模・現状・予測（2021年-2027年） ACTH is an adrenocorticotropic hormone, which is a hormone secreted by the anterior pituitary gland, which can maintain the normal form and function of the adrenal glands. The main role of ACTH is to promote the secretion of glucocorticoids by the adrenal cortex, maintaining the normal physiological…- 世界のアルギナーゼ欠損症治療市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Arginase Deficiency Treatment Market The global Arginase Deficiency Treatme…
- 世界のアルギナーゼ欠損症治療薬市場規模・現状・予測（2021年-2027年） Argininemia, also called arginase deficiency, is an autosomal recessive urea cycle disorder where adeficiency of the enzyme arginase causes a buildup of arginine and ammonia in the blood. Market Analysis and Insights: Global Arginase Deficiency Therapeutics Market The global Arginase Deficiency Ther…
- 世界のCDKL5欠乏症（CDD）市場規模・現状・予測（2021年-2027年） CDKL5 deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE), X-linked genetic condition which results in early-onset, difficult to control seizures and severe neuro-developmental impairment. CDKL5 stands for cyclin-dependent kinase-like 5 and mutations in this gene were fi…
- 世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年） Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AAT…